The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate-dependent
- PMID: 2331566
- PMCID: PMC1917517
- DOI: 10.1111/j.1476-5381.1990.tb14665.x
The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate-dependent
Abstract
1. The frequency-dependent electrophysiological effects of lignocaine, sotalol, and their combination were studied in dog isolated cardiac Purkinje fibres, both at various constant rates of stimulation and following abrupt changes in pacing cycle length. 2. The combined effect of 18 microM lignocaine and 30 microM sotalol selectively lengthened duration of premature action potentials evoked at a diastolic interval of 40 ms (from 172.2 +/- 5.4 to 201.7 +/- 4.9 ms, n = 6, P less than 0.01) without significantly changing the durations of action potentials evoked at the basic cycle length of 500 ms (259.1 +/- 7.7 vs 251.9 +/- 3.9 ms, n = 11). 3. The combination of lignocaine with sotalol, like lignocaine alone, displayed a use-dependent depression of Vmax and revealed a slow component for a recovery of Vmax (tau = 173.5 +/- 16.0 ms, n = 5). 4. The kinetics for restitution of action potential duration were also slowed by the combination of the two dwo drugs (tau f = 173.6 +/- 16.7, before, vs 268.5 +/- 8.5 ms, after; n = 5, P less than 0.01), while the maximum action potential duration attained in this relation was not increased as it was by sotalol alone. 5. Lignocaine, therefore, appeared to inhibit the sotalol-induced lengthening of action potential duration at slow pacing rates and at long diastolic intervals. The combination of lignocaine with sotalol also completely abolished the occurrence of sotalol-induced early after depolarizations. 6. Finally, sotalol alone moderately increased the range of premature action potential durations, while the combination of the two drugs significantly decreased this parameter. 7. These findings indicate that the combination of lignocaine with sotalol may provide important, and unique, beneficial electrophysiological alterations that might be expected to provide enhanced antiarrhythmic efficacy in patients.
Similar articles
-
Sotalol and mexiletine: combination of rate-dependent electrophysiological effects.J Cardiovasc Pharmacol. 1990 Oct;16(4):557-67. doi: 10.1097/00005344-199010000-00006. J Cardiovasc Pharmacol. 1990. PMID: 1706796
-
Modulation of the effects of sotalol on Purkinje strand electromechanical characteristics.Can J Physiol Pharmacol. 1989 Nov;67(11):1463-7. doi: 10.1139/y89-236. Can J Physiol Pharmacol. 1989. PMID: 2483356
-
Concentration- and rate-dependent electrophysiological effects of restacorin on isolated canine Purkinje fibres.Naunyn Schmiedebergs Arch Pharmacol. 1990 Dec;342(6):691-7. doi: 10.1007/BF00175714. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2096301
-
Rate and concentration-dependent effects of UK-68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and Vmax.Br J Pharmacol. 1991 Jun;103(2):1568-72. doi: 10.1111/j.1476-5381.1991.tb09828.x. Br J Pharmacol. 1991. PMID: 1884111 Free PMC article.
-
Rate-dependent electrophysiological effects of OPC-8212: comparison to sotalol.Eur J Pharmacol. 1989 May 30;164(3):487-96. doi: 10.1016/0014-2999(89)90256-2. Eur J Pharmacol. 1989. PMID: 2767119
Cited by
-
The electrical restitution of the non-propagated cardiac ventricular action potential.Pflugers Arch. 2024 Jan;476(1):9-37. doi: 10.1007/s00424-023-02866-0. Epub 2023 Oct 3. Pflugers Arch. 2024. PMID: 37783868 Free PMC article. Review.
-
Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.Drugs. 1993 Oct;46(4):678-719. doi: 10.2165/00003495-199346040-00007. Drugs. 1993. PMID: 7506652 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources